In addition, other studies suggest that CKI can inhibit mouse sarcoma growth and reduce tumor-induced hyperalgesia via the AKT and TRPV1 signalling pathways by reducing the phosphorylation of ERK and AKT kinases and BAD [18]. Here, CHKA is linked to neoplasm.